ICUI · XBRL financial data

Icu Medical financial statements, every quarter

The same tables from 12 filings, lined up. Matched by XBRL tag: renamed lines keep their history.

How these numbers work

Every number comes from the company's XBRL financial data filed with the SEC, and each one links to its filing.
Lines are matched by XBRL tag, so a line renamed between filings keeps its history.
* marks a quarter worked out from the filing totals: the 10-K year minus the first three quarters, or a year-to-date total minus the earlier one. Fourth-quarter earnings per share is fourth-quarter net income over the fourth-quarter weighted shares.
0 means a filing states zero; a dash (—) means no filing states that number.
“year only” means the 10-K gives the full year but not the quarters needed to work out the fourth. A worked-out quarter of revenue, cost of revenue or operating cash flow more than twice the company's largest quarter of the two years before is shown this way too.
Gross profit is shown as the company reports it; a worked-out quarter must equal revenue less cost of revenue for that quarter, or it is a dash.
Operating income can be above gross profit when the company books other operating income between the two, shown on its own line.
Shares outstanding come from each filing's cover page, as of the date printed there.
Quarters are fiscal: Q2 FY27 is the second quarter of the company's fiscal 2027.

Income statement

Fiscal quarters (ICUI's year ends in late December)

In millions of dollars	Q3 FY23Sep 30, 2023	Q4 FY23Dec 31, 2023	Q1 FY24Mar 31, 2024	Q2 FY24Jun 30, 2024	Q3 FY24Sep 30, 2024	Q4 FY24Dec 31, 2024	Q1 FY25Mar 31, 2025	Q2 FY25Jun 30, 2025	Q3 FY25Sep 30, 2025	Q4 FY25Dec 31, 2025	Q1 FY26Mar 31, 2026	Q2 FY26Jun 30, 2026
Revenue	553	588*	567	596	589	630*	605	549	537	541*	530	552
Revenue from contracts with customers	553	—	567	596	589	—	605	549	537	—	530	552
Cost of revenue	369	—	381	389	384	—	395	341	336	—	324	317
Cost of goods and services sold	—	year only	—	—	—	year only	—	—	—	year only	—	—
Gross profit	184	—	185	207	205	—	210	208	201	—	206	235
Research and development	21	22*	22	23	21	22*	23	22	21	21*	21	23
Selling, general and administrative	149	155*	158	160	163	159*	157	159	153	156*	155	152
Total operating expenses	161	184*	196	200	197	190*	197	197	187	197*	193	196
Other operating income (expense)	—	year only	—	—	—	year only	—	—	—	year only	—	—
Operating income (loss)	23	(12)*	(11)	8	8	38*	13	11	14	6*	14	39
Interest expense	24	32*	24	24	25	34*	22	21	20	31*	16	16
Income tax expense (benefit)	(13)	(20)*	3	2	15	32*	5	1	(1)	(3)*	(35)	7
Net income (loss)	7	(17)*	(39)	(21)	(33)	(24)*	(15)	35	(3)	(16)*	30	19
Earnings per share, basic USD per share	0.30	(0.71)*	(1.63)	(0.88)	(1.35)	(0.97)*	(0.63)	1.43	(0.14)	(0.64)*	1.22	0.76
Earnings per share, diluted USD per share	0.30	(0.72)*	(1.63)	(0.88)	(1.35)	(0.97)*	(0.63)	1.43	(0.14)	(0.61)*	1.20	0.76
Weighted average shares, basic millions of shares	24	24*	24	24	24	24*	25	25	25	25*	25	25
Weighted average shares, diluted millions of shares	24	24*	24	24	24	24*	25	25	25	26*	25	25

Balance sheet

CSV

Fiscal quarters (ICUI's year ends in late December)

In millions of dollars	Q3 FY23Sep 30, 2023	Q4 FY23Dec 31, 2023	Q1 FY24Mar 31, 2024	Q2 FY24Jun 30, 2024	Q3 FY24Sep 30, 2024	Q4 FY24Dec 31, 2024	Q1 FY25Mar 31, 2025	Q2 FY25Jun 30, 2025	Q3 FY25Sep 30, 2025	Q4 FY25Dec 31, 2025	Q1 FY26Mar 31, 2026	Q2 FY26Jun 30, 2026
Cash and cash equivalents	197	254	251	303	313	309	290	300	300	308	288	298
Marketable securities	2	1	0	0	0	0	—	—	—	—	—	—
Marketable securities, non-current	0	0	—	—	—	—	—	—	—	—	—	—
Accounts receivable	162	162	145	152	174	183	171	179	192	181	201	184
Inventory	760	709	693	683	692	585	590	616	622	616	606	607
Prepaid and other current assets	84	74	83	81	74	70	75	84	94	86	118	122
Total current assets	1,219	1,221	1,188	1,236	1,258	1,442	1,424	1,180	1,207	1,191	1,213	1,211
Property and equipment, net	609	613	603	594	596	443	442	452	456	452	445	447
Right-of-use asset	74	70	65	66	60	53	58	59	57	54	51	39
Goodwill	1,444	1,472	1,459	1,451	1,478	1,433	1,455	1,502	1,499	1,500	1,486	1,484
Total assets	4,377	4,378	4,288	4,287	4,305	4,204	4,185	4,107	4,103	4,051	4,014	3,971
Accounts payable	149	150	152	156	169	148	180	169	172	154	174	149
Accrued liabilities	251	268	248	300	326	307	279	314	316	315	315	322
Current portion of long-term debt	46	51	51	51	51	51	48	0	0	19	19	19
Total current liabilities	464	482	455	512	550	556	549	483	493	499	518	498
Long-term debt	1,589	1,578	1,566	1,555	1,543	1,532	1,489	1,338	1,314	1,266	1,262	1,212
Lease liability, non-current	57	53	50	52	45	41	48	49	47	44	41	37
Retained earnings	825	808	768	747	714	690	675	710	707	691	721	740
Total stockholders' equity	2,098	2,123	2,068	2,038	2,049	1,965	1,988	2,116	2,127	2,124	2,112	2,152
Total liabilities and equity	4,377	4,378	4,288	4,287	4,305	4,204	4,185	4,107	4,103	4,051	4,014	3,971
Common shares outstanding (cover page) millions of shares	24	24	24	24	24	25	25	25	25	25	25	25

Cash flows

CSV

Fiscal quarters (ICUI's year ends in late December)

In millions of dollars	Q3 FY23Sep 30, 2023	Q4 FY23Dec 31, 2023	Q1 FY24Mar 31, 2024	Q2 FY24Jun 30, 2024	Q3 FY24Sep 30, 2024	Q4 FY24Dec 31, 2024	Q1 FY25Mar 31, 2025	Q2 FY25Jun 30, 2025	Q3 FY25Sep 30, 2025	Q4 FY25Dec 31, 2025	Q1 FY26Mar 31, 2026	Q2 FY26Jun 30, 2026
Net income (loss)	7	(17)*	(39)	(21)	(33)	(24)*	(15)	35	(3)	(16)*	30	19
Stock-based compensation	11*	11*	12	11*	12*	13*	12	14*	15*	14*	14	12*
Depreciation and amortization	58*	57*	56	55*	56*	53*	49	50*	51*	51*	50	50*
Net cash from operating activities	35*	91*	46	82*	36*	40*	51	11*	57*	61*	39	80*
Purchases of property and equipment	21*	30*	16	19*	20*	24*	15	20*	29*	25*	11	19*
Net cash from investing activities	(25)*	(31)*	(18)	(22)*	(23)*	(27)*	(17)	187*	(30)*	(18)*	(11)	(20)*
Share repurchases	—	year only	—	—	—	year only	—	—	—	year only	—	—
Repayments of long-term debt	7*	7*	13	13*	13*	13*	48	200*	25*	30*	5	50*
Net cash from financing activities	(6)*	(8)*	(27)	(10)*	(10)*	(8)*	(56)	(195)*	(26)*	(34)*	(44)	(50)*
Net change in cash	1*	57*	(3)	51*	10*	(4)*	(19)	10*	(0)*	8*	(20)	10*

Compare with peers

SIC 3841 and related industry codes, similar size. Each row is the latest quarter reported.

How peers are chosen

SIC 3841 and related industry codes with public float (or, where float is missing, quarterly revenue) between 0.2x and 5x the company's.
Each row is the latest quarter the company has reported, named in the Quarter column; when that filing is a 10-K, it is the fourth quarter, never the full year.
Runway shows only for companies burning cash with under $10B of public float.
* marks a quarter worked out from the filing totals: for a 10-Q, the year-to-date total less the earlier one.

Company	Cash ($M)	Revenue, quarter ($M)	Operating cash flow, quarter ($M)	Shares outstanding	Runway	Quarter
Icu Medical	298	552	80*	25.0M	—	Q2 FY26 10-QJun 30, 2026
PROCEPT BioRobotics	228	94	(19)*	57.3M	11.8 quarters	Q2 FY26 10-QJun 30, 2026
Dentsply Sirona	239	898	99*	199.4M	—	Q2 FY26 10-QJun 30, 2026
Inspire Medical Systems	191	207	46*	29.0M	—	Q3 FY26 10-QSep 30, 2026
Masimo	125	404	45	52.4M	—	Q1 FY26 10-QApr 4, 2026
LivaNova	517	391	67*	55.1M	—	Q2 FY26 10-QJun 30, 2026
Envista Holdings	1,126	731	119*	160.6M	—	Q2 FY26 10-QJul 3, 2026
Integer Holdings	14	450	37*	34.0M	—	Q3 FY26 10-QOct 2, 2026
TransMedics Group	491	190	17*	34.7M	—	Q2 FY26 10-QJun 30, 2026

Not investment advice. Not affiliated with the U.S. SEC.